List of Excipients in API palovarotene
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing palovarotene
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Ipsen Biopharmaceuticals Inc | SOHONOS | palovarotene | 15054-0010 | CELLULOSE, MICROCRYSTALLINE | 2030-08-16 |
| Ipsen Biopharmaceuticals Inc | SOHONOS | palovarotene | 15054-0010 | CROSCARMELLOSE SODIUM | 2030-08-16 |
| Ipsen Biopharmaceuticals Inc | SOHONOS | palovarotene | 15054-0010 | FERROSOFERRIC OXIDE | 2030-08-16 |
| Ipsen Biopharmaceuticals Inc | SOHONOS | palovarotene | 15054-0010 | GELATIN | 2030-08-16 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for palovarotene
Excipient focus: CELLULOSE, MICROCRYSTALLINE
palovarotene drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | palovarotene | 15054-0010 |
| >Company | >Ingredient | >NDC |
palovarotene drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
palovarotene drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | palovarotene | 15054-0010 |
| >Company | >Ingredient | >NDC |
palovarotene drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
palovarotene drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | palovarotene | 15054-0010 |
| >Company | >Ingredient | >NDC |
palovarotene drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
palovarotene drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | palovarotene | 15054-0010 |
| >Company | >Ingredient | >NDC |
palovarotene drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
palovarotene drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | palovarotene | 15054-0010 |
| >Company | >Ingredient | >NDC |
palovarotene drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
palovarotene drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | palovarotene | 15054-0010 |
| >Company | >Ingredient | >NDC |
palovarotene drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
palovarotene drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | palovarotene | 15054-0010 |
| >Company | >Ingredient | >NDC |
palovarotene drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
palovarotene drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | palovarotene | 15054-0010 |
| >Company | >Ingredient | >NDC |
palovarotene drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
palovarotene drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | palovarotene | 15054-0010 |
| >Company | >Ingredient | >NDC |
palovarotene drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
palovarotene drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | palovarotene | 15054-0010 |
| >Company | >Ingredient | >NDC |
palovarotene drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
palovarotene drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | palovarotene | 15054-0010 |
| >Company | >Ingredient | >NDC |
palovarotene drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
palovarotene drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ipsen Biopharmaceuticals Inc | palovarotene | 15054-0010 |
| >Company | >Ingredient | >NDC |
palovarotene drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
